Published on in Vol 21, No 9 (2019): September

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/15505, first published .
Telemonitoring of Crohn’s Disease and Ulcerative Colitis (TECCU): Cost-Effectiveness Analysis

Telemonitoring of Crohn’s Disease and Ulcerative Colitis (TECCU): Cost-Effectiveness Analysis

Telemonitoring of Crohn’s Disease and Ulcerative Colitis (TECCU): Cost-Effectiveness Analysis

Journals

  1. Muzammil S. Telehealth: Is It Only for the Rural Areas? A Review of Its Wider Use. Telehealth and Medicine Today 2020;5 View
  2. Kernebeck S, Busse T, Böttcher M, Weitz J, Ehlers J, Bork U. Impact of mobile health and medical applications on clinical practice in gastroenterology. World Journal of Gastroenterology 2020;26(29):4182 View
  3. Del Hoyo J, Nos P, Faubel R, Bastida G, Muñoz D, Valero-Pérez E, Garrido-Marín A, Bella P, Peña B, Savini C, Aguas M. Adaptation of TECCU App Based on Patients´ Perceptions for the Telemonitoring of Inflammatory Bowel Disease: A Qualitative Study Using Focus Groups. International Journal of Environmental Research and Public Health 2020;17(6):1871 View
  4. Alvarez Quintero P, Castiblanco F, Correa A, Guío Reyez A. COVID-19, médicos, gastroenterología y emociones. Revista Colombiana de Gastroenterología 2020;35(Supl. 1):64 View
  5. Del Hoyo J, Aguas M. Implementing telemedicine in inflammatory bowel disease: Is COVID-19 the definitive trigger?. Gastroenterología y Hepatología 2020;43(8):415 View
  6. Del Hoyo J, Aguas M. Cost-effectiveness of Telemedicine-directed Specialized vs Standard Care for Patients With Inflammatory Bowel Diseases in a Randomized Trial. Clinical Gastroenterology and Hepatology 2021;19(1):206 View
  7. Del Hoyo J, Aguas M. Implementing telemedicine in inflammatory bowel disease: Is COVID-19 the definitive trigger?. Gastroenterología y Hepatología (English Edition) 2020;43(8):415 View
  8. Östlund I, Werner M, Karling P. Self-monitoring with home based fecal calprotectin is associated with increased medical treatment. A randomized controlled trial on patients with inflammatory bowel disease. Scandinavian Journal of Gastroenterology 2021;56(1):38 View
  9. Yu Q, Zhu C, Feng S, Xu L, Hu S, Chen H, Chen H, Yao S, Wang X, Chen Y. Economic Burden and Health Care Access for Patients With Inflammatory Bowel Diseases in China: Web-Based Survey Study. Journal of Medical Internet Research 2021;23(1):e20629 View
  10. Bonnaud G, Haennig A, Altwegg R, Caron B, Boivineau L, Zallot C, Gilleta de Saint-Joseph C, Moreau J, Gonzalez F, Reynaud D, Faure P, Aygalenq P, Combis J, Peyrin-Biroulet L. Real-life pilot study on the impact of the telemedicine platform EasyMICI–MaMICI® on quality of life and quality of care in patients with inflammatory bowel disease. Scandinavian Journal of Gastroenterology 2021;56(5):530 View
  11. Löser C, Fröhlich A, Poortinga S, Dippel E, Paul C, Czech C, Wiemann L, Bergmann L, Bieber T, Balakirski G. Telephone follow‐up for monitoring of complications and boosting patient satisfaction after inpatient dermatosurgery: a prospective two‐center study. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 2022;20(1):121 View
  12. Peng L, Hu S, Yu Q, Chen Y. Challenging the Surge of Inflammatory Bowel Disease: The Role of the China Crohn’s and Colitis Foundation in the Healthcare Landscape of Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2022;28(Supplement_2):S9 View
  13. Löser C, Fröhlich A, Poortinga S, Dippel E, Paul C, Czech C, Wiemann L, Bergmann L, Bieber T, Balakirski G. Poststationäre telefonische OP‐Nachsorge zur Erfassung von Komplikationen und Steigerung der Patientenzufriedenheit nach dermatochirurgischen Eingriffen: Eine prospektive bizentrische Studie. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 2022;20(1):121 View
  14. Del Hoyo J, Millán M, Garrido-Marín A, Aguas M. Are we ready for telemonitoring inflammatory bowel disease? A review of advances, enablers, and barriers. World Journal of Gastroenterology 2023;29(7):1139 View
  15. Burisch J, Zhao M, Odes S, De Cruz P, Vermeire S, Bernstein C, Kaplan G, Duricova D, Greenberg D, Melberg H, Watanabe M, Ahn H, Targownik L, Pittet V, Annese V, Park K, Katsanos K, Høivik M, Krznaric Z, Chaparro M, Loftus E, Lakatos P, Gisbert J, Bemelman W, Moum B, Gearry R, Kappelman M, Hart A, Pierik M, Andrews J, Ng S, D'Inca R, Munkholm P. The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission. The Lancet Gastroenterology & Hepatology 2023;8(5):458 View
  16. Yao J, Fekadu G, Jiang X, You J, Pittet V. Telemonitoring for patients with inflammatory bowel disease amid the COVID-19 pandemic—A cost-effectiveness analysis. PLOS ONE 2022;17(4):e0266464 View
  17. Gentili A, Failla G, Melnyk A, Puleo V, Tanna G, Ricciardi W, Cascini F. The cost-effectiveness of digital health interventions: A systematic review of the literature. Frontiers in Public Health 2022;10 View
  18. del Hoyo J, Millán M, Garrido-Marín A, Nos P, Barreiro-de Acosta M, Bujanda L, de la Portilla F, Aguas M. Changes in the management of IBD patients since the onset of COVID-19 pandemic. A path toward the implementation of telemedicine in Spain?. Gastroenterología y Hepatología (English Edition) 2022;45(9):697 View
  19. del Hoyo J, Millán M, Garrido-Marín A, Nos P, Barreiro-de Acosta M, Bujanda L, de la Portilla F, Aguas M. Changes in the management of IBD patients since the onset of COVID-19 pandemic. A path toward the implementation of telemedicine in Spain?. Gastroenterología y Hepatología 2022;45(9):697 View
  20. Saifuddin A, Kent A, Mehta S, Sebastian S. Editorial: the impact of COVID on the management of IBD flares: different care but similar outcomes—authors' reply. Alimentary Pharmacology & Therapeutics 2023;57(1):156 View
  21. Gordon M, Sinopoulou V, Lakunina S, Gjuladin-Hellon T, Bracewell K, Akobeng A. Remote care through telehealth for people with inflammatory bowel disease. Cochrane Database of Systematic Reviews 2023;2023(5) View
  22. Takahashi M, Nunotani M, Aoyama N. Construction of an Explanatory Model for Quality of Life in Outpatients with Ulcerative Colitis. Inflammatory Intestinal Diseases 2023;8(1):23 View
  23. Gravina A, Pellegrino R, Durante T, Palladino G, D'Onofrio R, Mammone S, Arboretto G, Auletta S, Imperio G, Ventura A, Romeo M, Federico A. Telemedicine in inflammatory bowel diseases: A new brick in the medicine of the future?. World Journal of Methodology 2023;13(4):194 View
  24. Fantini M, Loddo E, Petrillo A, Onali S. Telemedicine in inflammatory bowel disease from its origin to the post pandemic golden age: A narrative review. Digestive and Liver Disease 2024;56(1):1 View
  25. Le Goff-Pronost M, Bongiovanni-Delarozière I. Economic evaluation of remote patient monitoring and organizational analysis according to patient involvement: a scoping review. International Journal of Technology Assessment in Health Care 2023;39(1) View